Get it on Google Play

Kane Biotech receives FDA clearance for wound cleanser product

February 17, 2026 7:25 AM EST Send to a Friend
Kane Biotech Inc. (TSXV: KNE) announced it received U.S. Food and Drug Administration 510(k) clearance for its revyve Antimicrobial Skin ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login